Blood test could predict if you’ll live two more years

Getting older brings uncertainty. Doctors struggle to predict who will stay healthy and who faces serious health problems ahead. New research suggests the answer might already be flowing through our blood.

Scientists at Duke Health and the University of Minnesota found that tiny RNA molecules called piRNAs can predict whether older adults will survive at least two more years. The discovery could lead to simple blood tests that spot health risks early and guide treatment decisions.

How does it work?

The researchers studied blood samples from more than 1,200 adults aged 71 and older. They used artificial intelligence and machine learning to analyze 187 health factors and 828 different small RNA molecules.

The key finding: lower levels of certain piRNAs predicted longer survival. Just six specific piRNAs could predict two-year survival with 86% accuracy. The team confirmed these results in a separate group of older adults.

"The combination of just a few piRNAs was the strongest predictor of two-year survival in older adults—stronger than age, lifestyle habits, or any other health measures we examined," says Virginia Byers Kraus, the study's senior author and professor at Duke University School of Medicine.

People who lived longer consistently had lower levels of specific piRNAs. This mirrors patterns seen in simple organisms, where reducing these molecules can extend lifespan.

Why does it matter?

Current health assessments rely on factors like:

• Age and medical history
• Cholesterol levels
• Physical activity
• Blood pressure and other vital signs

But piRNAs outperformed all of these traditional measures for predicting short-term survival. The blood test approach offers several advantages:

• Simple and minimally invasive
• More accurate than existing methods
• Could identify risks before symptoms appear
• May guide personalized treatment plans

"When these molecules are present in higher amounts, it may signal that something in the body is off-track," Kraus explains. "Understanding why could open new possibilities for therapies that promote healthy aging."

The context

piRNAs are small pieces of genetic material that help control cell development, tissue repair, and immune function. Scientists call them "micromanagers" because they regulate many biological processes.

Previous studies focused mainly on piRNAs in reproductive cells. This research breaks new ground by examining their role in blood and aging. The molecules appear to influence longevity directly, not just reflect existing health problems.

The research team plans to study whether treatments or lifestyle changes can alter piRNA levels. They're particularly interested in testing newer medications like GLP-1-based therapies, which are already used for diabetes and weight management.

"We are only beginning to understand how powerful they are," Kraus says. "This research suggests we should be able to identify short-term survival risk using a practical, minimally invasive blood test—with the ultimate goal of improving health as we age."

For longer-term survival predictions, lifestyle factors still matter more. But piRNAs provide valuable insights into the biological processes of aging that traditional health measures miss.